Investors & Partners
Investors
Selecta Biosciences and Cartesian Therapeutics have merged. For investor information, please click here.
Partners
We welcome strategic collaborations that expand the therapeutic applications of our technology platform for autoimmune diseases.
Grants
Our research has been recognized by over $7 million in competitive grant funding from the National Institutes of Health (NIH) and the Maryland Stem Cell Research Fund (MSCRF). We are grateful to our funding partners for helping to pioneer RNA Cell Therapies.
Contact Us
If you are interested in exploring a partnership with us, please contact us at info@cartesiantx.com